Title : Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report.

Pub. Date : 2021

PMID : 34320493






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report. lorlatinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens
2 Tyrosine kinase inhibitors (TKI) with activity against ROS1 including lorlatinib substantially improved the outcome of this patient population. lorlatinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens